Orphazyme gets another annual report extension approved

Biotech company Orphazyme has been granted another new deadline for the release of its full-year 2021 report, the company has announced in a press release on Tuesday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme files for delisting in US
For subscribers